Application
IHC-P analysis of human kidney tissue using ILF2 antibody at 4.0-8.0μg/ml.Application
IHC-P analysis of human heart tissue using ILF2 antibody at 4.0-8.0μg/ml.Application
WB analysis of Jurkat cells using ILF2 antibody at 1.25μg/ml.Application
WB analysis of Jurkat cells using ILF2 antibody at 2.5μg/ml. Lane A : Primary antibody Lane B : Primary antibody + blocking peptide| Product Name | ILF2 antibody, C-term |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to ILF2The protein encoded by this gene is a transcription factor required for T-cell expression of the interleukin 2 gene. It also binds RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. The encoded 45 kDa protein (NF45, ILF2) forms a complex with the 90 kDa interleukin enhancer-binding factor 3 (NF90, ILF3), and this complex has been shown to affect the redistribution of nuclear mRNA to the cytoplasm, to repair DNA breaks by nonhomologous end joining, and to negatively regulate the microRNA processing pathway. Knockdown of NF45 or NF90 protein retards cell growth, possibly by inhibition of mRNA stabilization. Alternative splicing results in multiple transcript variants. Related pseudogenes have been found on chromosomes 3 and 14. [provided by RefSeq, Dec 2014] |
| Immunogen | A synthetic peptide corresponding to a C-terminal region of Human ILF2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC-PWB |
| *Optimal dilutions/concentrations should be determined by the researcher.
: |
|
| Species Reactivity | Human |
| Predicted Reactivity | Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 93% |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Synonyms | NF45 ILF2 PRO3063 |
|---|---|
| Target | ILF2 |
| Molecular Weight(MW) | 43 KDa (note) |
Application
IHC-P analysis of human kidney tissue using ILF2 antibody at 4.0-8.0μg/ml.
Application
IHC-P analysis of human heart tissue using ILF2 antibody at 4.0-8.0μg/ml.
Application
WB analysis of Jurkat cells using ILF2 antibody at 1.25μg/ml.
Application
WB analysis of Jurkat cells using ILF2 antibody at 2.5μg/ml. Lane A : Primary antibody Lane B : Primary antibody + blocking peptide| Positive Control | Jurkat |
|---|---|
| Application Notes | *Optimal dilutions/concentrations should be determined by the researcher.
: |
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. For short-term storage, store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
